Insider Trading & Ownership of Stephanie Okey

Location
Boston, MA
Summary
The estimated net worth of Stephanie Okey is at least $1,325,651 dollars as of 12 Mar 2026. Stephanie Okey is the Director of PTC THERAPEUTICS, INC. and owns shares of PTC THERAPEUTICS, INC. (PTCT) stock worth about $798K. Stephanie Okey is the Director of Crinetics Pharmaceuticals, Inc. and owns shares of Crinetics Pharmaceuticals, Inc. (CRNX) stock worth about $527.6K.
Signature
/s/ Avraham S. Adler, Attorney-in-Fact
All Insider Reports
All Insider Reports

Follow Filing Activity

Follow Stephanie Okey and return when a new Insider Trading filing changes the record on this page.

This uses the existing product follow flow to surface future filing-backed changes without guessing what they mean.

Sign up to save research and follow filings

Quick Takeaways

  • Stephanie Okey has 4 issuer positions tracked on this page.
  • Estimated disclosed ownership value: $1,325,651.
  • Recent insider filing activity is available below.

What Changed

  • Largest disclosed position: PTC THERAPEUTICS, INC. ($798,040).
  • Past-year value change for that position: -$1,463,076.

Why This Matters

  • This page translates Forms 3/4/5 into a quick ownership context before you inspect each transaction row.
  • You can cross-check role, issuer, and filing chronology directly against the SEC source.

Source Evidence

Filed on Form 4

Insider ownership context is sourced from SEC Forms 3, 4, and 5.

See Original Filing

Ownership of Stephanie Okey

Symbol Company Relationship Holdings Value Past Year Net Change Change % Report Period
PTCT PTC THERAPEUTICS, INC. Director $798,040 -$1,463,076 -65% 10 Mar 2026
CRNX Crinetics Pharmaceuticals, Inc. Director $527,611 -$119,010 -18% 03 Mar 2026
CTLT Catalent, Inc. Director $0 18 Dec 2024
ALBO ALBIREO PHARMA, INC. Director 02 Mar 2023

Insider Transactions Reported by Stephanie Okey:

Sym Company Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Here you can make detailed settings or revoke your consent (in part if necessary) with effect for the future. For further information, please refer to our Privacy Policy .